Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting

2016 ◽  
Vol 36 (2) ◽  
pp. 166-173 ◽  
Author(s):  
Bethany R. Shoulders ◽  
Jessica R. Crow ◽  
Stephanie L. Davis ◽  
Glenn J. Whitman ◽  
Melanie Gavin ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Continuous Infusion ◽  
Coronary Artery Bypass ◽  
Artery Bypass ◽  
Surgical Site Infections ◽  
Bypass Grafting ◽  
Artery Bypass Grafting

Costs versus earnings in colon surgery and coronary artery bypass grafting under a prospective payment system: Sufficient financial incentives to reduce surgical site infections?

2018 ◽  
Vol 39 (10) ◽  
pp. 1246-1249
Author(s):  
Fabrice Juchler ◽  
Jan A. Roth ◽  
Alexander Schweiger ◽  
Marc Dangel ◽  
Massimo Gugliotta ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Coronary Artery Bypass ◽  
Financial Incentives ◽  
Artery Bypass ◽  
Surgical Site Infections ◽  
Prospective Payment System ◽  
Colon Surgery ◽  
Bypass Grafting ◽  
Artery Bypass Grafting

AbstractBased on a surgical site infection (SSI) cohort at an academic center, we showed a median potentially preventable loss per non-SSI case of $17,916 in colon surgery and of $34,741 in coronary artery bypass grafting.

Sign in / Sign up

Export Citation Format

Share Document